Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine

To the best of our knowledge, the clinical implications of using ribonucleoside reductase subunit M1 (RRM1) in patients who undergo curative resection and adjuvant chemotherapy have not been established. In the present study, the clinical data from 101 consecutive patients who underwent macroscopica...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoyama, Toru, Miyagi, Yohei, Murakawa, Masaaki, Yamaoku, Koichiro, Atsumi, Yosuke, Shiozawa, Manabu, Ueno, Makoto, Morimoto, Manabu, Oshima, Takashi, Yukawa, Norio, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431334/
https://www.ncbi.nlm.nih.gov/pubmed/28521448
http://dx.doi.org/10.3892/ol.2017.5935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431334/
https://www.ncbi.nlm.nih.gov/pubmed/28521448
http://dx.doi.org/10.3892/ol.2017.5935

Ejemplares similares